SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Panacea Biotec informs about cessation of senior management personnel

01 Apr 2025 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI LODR Regulations’), Panacea Biotec has informed that Sunil Anand, Associate Director - Finance & Corporate Affairs of the Company, designated as Senior Management Personnel, has superannuated from the services of the Company on March 31, 2025 after having served the Company as a Whole-time Director / Associate Director for over two decades. Consequently, Sunil Anand has ceased to be a Senior Management Personnel on March 31, 2025. Since the above change in Senior Management Personnel is due to superannuation, the requirement for the Resignation Letter is not applicable in this case. The Management of the Company express deep appreciation and gratitude to the aforesaid senior management personnel for his extensive contribution and guidance towards the business growth of the Company, during his long association with the Company. The details required to be disclosed under Regulation 30 of the SEBI LODR Regulations read along with SEBI circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, are enclosed as Annexure - A.

The above information is a part of company’s filings submitted to BSE.

Panacea Biotec Share Price

358.00 5.30 (1.50%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×